Low-dose colestipol plus fenofibrate: Effects on plasma liproproteins, lecithin:cholesterol acyltransferase, and postheparin lipases in familial hypercholesterolemia
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 38 (3) , 271-274
- https://doi.org/10.1016/0026-0495(89)90086-3
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The effect of combined fenofibrate and cholestyramine therapy on low-density lipoprotein kinetics in familial hypercholesterolemia patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Gas—liquid chromatographic determination of procetofenic acid in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1978
- A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activityClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955